These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6608131)

  • 1. DNA antibodies and complement in SLE patients. A follow-up study.
    Helve T; Kurki P; Teppo AM; Wegelius O
    Rheumatol Int; 1983; 3(3):129-32. PubMed ID: 6608131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating DNA-antibodies in systemic lupus erythematosus.
    Helve T; Teppo AM; Kurki P; Wegelius O
    Rheumatol Int; 1982; 2(3):103-6. PubMed ID: 6761831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
    Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic deficiency of C4, C2 or C1q and lupus syndromes. Association with anti-Ro (SS-A) antibodies.
    Meyer O; Hauptmann G; Tappeiner G; Ochs HD; Mascart-Lemone F
    Clin Exp Immunol; 1985 Dec; 62(3):678-84. PubMed ID: 3878757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune complexes, complement, and anti-DNA in exacerbations of systemic lupus erythematosus (SLE).
    Lloyd W; Schur PH
    Medicine (Baltimore); 1981 May; 60(3):208-17. PubMed ID: 7231154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA antibodies with and without complement-binding ability.
    Teppo AM; Kurki P; Helve T; Wegelius O
    Rheumatol Int; 1984; 4(4):173-6. PubMed ID: 6484446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
    Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: a controlled study of 126 consecutive patients.
    Katsumata Y; Miyake K; Kawaguchi Y; Okamoto Y; Kawamoto M; Gono T; Baba S; Hara M; Yamanaka H
    Arthritis Rheum; 2011 Aug; 63(8):2436-44. PubMed ID: 21506094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential characteristics of immune-bound antibodies in diffuse proliferative and membranous forms of lupus glomerulonephritis.
    Roberts JL; Wyatt RJ; Schwartz MM; Lewis EJ
    Clin Immunol Immunopathol; 1983 Nov; 29(2):223-41. PubMed ID: 6605223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating DNA-anti-DNA complexes in lupus nephritis and idiopathic nephritis.
    Williams DG; Adu D
    Proc Eur Dial Transplant Assoc; 1980; 17():629-36. PubMed ID: 6787585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anti-C1q antibodies in patients with systemic lupus erythematosus treated by rituximab].
    Tsanyan ME; Torgashina AV; Aleksandrova EN; Soloviev SK; Nasonov EL
    Ter Arkh; 2013; 85(5):53-9. PubMed ID: 23819340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in immunochemical characteristics of cryoglobulins in rheumatoid arthritis and systemic lupus erythematosus and their complement binding properties.
    Erhardt CC; Mumford P; Maini RN
    Ann Rheum Dis; 1984 Jun; 43(3):451-6. PubMed ID: 6611139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of complement components C1q, C3, C4 and C5 to a model immune complex in ELISA.
    Larsson A; Sjöquist J
    J Immunol Methods; 1989 Apr; 119(1):103-9. PubMed ID: 2785142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of Circulating Anti-C3b and Anti-C1q IgG to Lupus Nephritis and Its Flare.
    Birmingham DJ; Bitter JE; Ndukwe EG; Dials S; Gullo TR; Conroy S; Nagaraja HN; Rovin BH; Hebert LA
    Clin J Am Soc Nephrol; 2016 Jan; 11(1):47-53. PubMed ID: 26700439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship of renal histopathological lesions to immunoglobulin classes and complement fixation of anti-native DNA antibodies in systemic lupus erythematosus.
    Hashimoto H; Utagawa Y; Yamagata J; Okada T; Shiokawa Y; Suzuki S; Tomiyama T
    Scand J Rheumatol; 1983; 12(3):209-14. PubMed ID: 6353567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in plasma levels of interleukin-2 receptor in relation to disease exacerbations and levels of anti-dsDNA and complement in systemic lupus erythematosus.
    ter Borg EJ; Horst G; Limburg PC; Kallenberg CG
    Clin Exp Immunol; 1990 Oct; 82(1):21-6. PubMed ID: 2208793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Autoantibodies against the complement component C1q in systemic lupus erythematosus].
    Antes U; Heinz HP; Hartung K; Loos M
    Klin Wochenschr; 1990 Nov; 68(21):1066-70. PubMed ID: 2084321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of immune complexes in systemic lupus erythematosus with the C1q solid phase assay: correlation with nDNA antibodies and hypocomplementemia.
    Agnello V; Mitamura T
    Clin Immunol Immunopathol; 1987 Mar; 42(3):338-43. PubMed ID: 3493866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgG autoantibodies to complement C1q in pediatric-onset systemic lupus erythematosus.
    Ravelli A; Wisnieski JJ; Ramenghi B; Ballardini G; Zonta L; Martini A
    Clin Exp Rheumatol; 1997; 15(2):215-9. PubMed ID: 9196878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rises in anti-double stranded DNA antibody levels prior to exacerbations of systemic lupus erythematosus are not merely due to polyclonal B cell activation.
    ter Borg EJ; Horst G; Hummel E; Limburg PC; Kallenberg CG
    Clin Immunol Immunopathol; 1991 Apr; 59(1):117-28. PubMed ID: 2019007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.